Comparison of the acid suppression effects between low-dose esomeprazole and famotidine in healthy subjects
CONCLUSION: The PD parameters of esomeprazole 10 mg were comparable to those of famotidine after multiple doses. These findings provide support for further evaluating the use of 10 mg of esomeprazole as a treatment option for gastritis.PMID:37382329 | DOI:10.5414/CP204391 (Source: International Journal of Clinical Pharmacology and Therapeutics)
Source: International Journal of Clinical Pharmacology and Therapeutics - June 29, 2023 Category: Drugs & Pharmacology Authors: Ha-Yeon Kim Jun Gi Hwang Jae-Won Kim Chang Hwan Seong Ji Hyeon Lee Hyung Son Kim Hye Yun Kim Yu Kyong Kim Min Kyu Park Source Type: research
Comparison of the acid suppression effects between low-dose esomeprazole and famotidine in healthy subjects
CONCLUSION: The PD parameters of esomeprazole 10 mg were comparable to those of famotidine after multiple doses. These findings provide support for further evaluating the use of 10 mg of esomeprazole as a treatment option for gastritis.PMID:37382329 | DOI:10.5414/CP204391 (Source: Clinical Pharmacology and Therapeutics)
Source: Clinical Pharmacology and Therapeutics - June 29, 2023 Category: Drugs & Pharmacology Authors: Ha-Yeon Kim Jun Gi Hwang Jae-Won Kim Chang Hwan Seong Ji Hyeon Lee Hyung Son Kim Hye Yun Kim Yu Kyong Kim Min Kyu Park Source Type: research
Comparison of the acid suppression effects between low-dose esomeprazole and famotidine in healthy subjects
CONCLUSION: The PD parameters of esomeprazole 10 mg were comparable to those of famotidine after multiple doses. These findings provide support for further evaluating the use of 10 mg of esomeprazole as a treatment option for gastritis.PMID:37382329 | DOI:10.5414/CP204391 (Source: International Journal of Clinical Pharmacology and Therapeutics)
Source: International Journal of Clinical Pharmacology and Therapeutics - June 29, 2023 Category: Drugs & Pharmacology Authors: Ha-Yeon Kim Jun Gi Hwang Jae-Won Kim Chang Hwan Seong Ji Hyeon Lee Hyung Son Kim Hye Yun Kim Yu Kyong Kim Min Kyu Park Source Type: research
Variation in Fatty Acid Synthase, Ki67 and p53 Esophageal Mucosa Expressions in Barrett's Esophagus Patients Treated for One Year with Two Esomeprazole Different Regimens
Curr Issues Mol Biol. 2023 May 29;45(6):4701-4715. doi: 10.3390/cimb45060299.ABSTRACTBarrett's esophagus (BE) is an acquired pre-malignant condition that results from chronic gastroesophageal reflux. The malignant transformation occurred in 0.5% of patients/year and was independent of medical and endoscopic conservative treatments. Fatty acid synthase (FAS) is a multifunctional enzyme that catalyzes the synthesis of long-chain fatty acids from acetyl-coenzyme A, malonyl-coenzyme A, a reduced form of nicotinamide adenine dinucleotide phosphate (NADPH), and adenosine triphosphate. Activation of FAS is closely linked to malig...
Source: Current Issues in Molecular Biology - June 27, 2023 Category: Molecular Biology Authors: Pietro Crispino Tiziana Ciarambino Mauro Giordano Source Type: research
Variation in Fatty Acid Synthase, Ki67 and p53 Esophageal Mucosa Expressions in Barrett's Esophagus Patients Treated for One Year with Two Esomeprazole Different Regimens
Curr Issues Mol Biol. 2023 May 29;45(6):4701-4715. doi: 10.3390/cimb45060299.ABSTRACTBarrett's esophagus (BE) is an acquired pre-malignant condition that results from chronic gastroesophageal reflux. The malignant transformation occurred in 0.5% of patients/year and was independent of medical and endoscopic conservative treatments. Fatty acid synthase (FAS) is a multifunctional enzyme that catalyzes the synthesis of long-chain fatty acids from acetyl-coenzyme A, malonyl-coenzyme A, a reduced form of nicotinamide adenine dinucleotide phosphate (NADPH), and adenosine triphosphate. Activation of FAS is closely linked to malig...
Source: Current Issues in Molecular Biology - June 27, 2023 Category: Molecular Biology Authors: Pietro Crispino Tiziana Ciarambino Mauro Giordano Source Type: research
Variation in Fatty Acid Synthase, Ki67 and p53 Esophageal Mucosa Expressions in Barrett's Esophagus Patients Treated for One Year with Two Esomeprazole Different Regimens
Curr Issues Mol Biol. 2023 May 29;45(6):4701-4715. doi: 10.3390/cimb45060299.ABSTRACTBarrett's esophagus (BE) is an acquired pre-malignant condition that results from chronic gastroesophageal reflux. The malignant transformation occurred in 0.5% of patients/year and was independent of medical and endoscopic conservative treatments. Fatty acid synthase (FAS) is a multifunctional enzyme that catalyzes the synthesis of long-chain fatty acids from acetyl-coenzyme A, malonyl-coenzyme A, a reduced form of nicotinamide adenine dinucleotide phosphate (NADPH), and adenosine triphosphate. Activation of FAS is closely linked to malig...
Source: Current Issues in Molecular Biology - June 27, 2023 Category: Molecular Biology Authors: Pietro Crispino Tiziana Ciarambino Mauro Giordano Source Type: research
